These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 12223976

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.
    Eur J Dermatol; 2010 Sep; 20(4):465-71. PubMed ID: 20413372
    [Abstract] [Full Text] [Related]

  • 6. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC.
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [Abstract] [Full Text] [Related]

  • 7. Once daily application of a combination of calcipotriol and betamethasone dipropionate (Dovobet, Daivobet) for the treatment of psoriasis.
    Lui H, Shapiro J.
    Skin Therapy Lett; 2003 May; 8(Suppl 1):1-2. PubMed ID: 14961173
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and local safety of a calcipotriol/ betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris.
    Parslew R, Traulsen J.
    Eur J Dermatol; 2005 Jan; 15(1):37-9. PubMed ID: 15701591
    [Abstract] [Full Text] [Related]

  • 11. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
    Anstey AV, Kragballe K.
    Int J Dermatol; 2006 Aug; 45(8):970-5. PubMed ID: 16911387
    [Abstract] [Full Text] [Related]

  • 12. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G.
    Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
    [Abstract] [Full Text] [Related]

  • 13. Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
    Vakirlis E, Kastanis A, Lazaridou E, Loannides D, Chrysomallis F.
    Int J Clin Pharmacol Res; 2005 Jun; 25(4):165-8. PubMed ID: 16402632
    [Abstract] [Full Text] [Related]

  • 14. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G.
    Dermatology; 2006 Jun; 213(4):319-26. PubMed ID: 17135738
    [Abstract] [Full Text] [Related]

  • 15. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008 Jun; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
    Augustin M, Peeters P, Radtke M, Moehling U, Lapp C.
    Dermatology; 2007 Jun; 215(3):219-28. PubMed ID: 17823519
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
    Bottomley JM, Auland ME, Morais J, Boyd G, Douglas WS.
    Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
    [Abstract] [Full Text] [Related]

  • 18. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL.
    Drugs; 2011 Apr 16; 71(6):709-30. PubMed ID: 21504248
    [Abstract] [Full Text] [Related]

  • 19. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL.
    Am J Clin Dermatol; 2011 Dec 01; 12(6):421-4. PubMed ID: 21967117
    [Abstract] [Full Text] [Related]

  • 20. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
    Claréus BW, Houwing R, Sindrup JH, Wigchert S.
    Eur J Dermatol; 2009 Dec 01; 19(6):581-5. PubMed ID: 19726275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.